Press Company News: Press Release

Twitter Facebook Linkedin Envelope CYTENA’s B.SIGHTTM will reduce timelines and cut costs on single-cell microbiology research Freiburg, Germany -PRESS RELEASE-CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and leading provider of high-precision instruments for handling biological cells, has launched a new instrument to streamline single-cell isolation in microbiology research. The next generation B.SIGHT is taking the …

CYTENA launches new generation of B.SIGHT, a fully automated single-cell dispenser for microorganisms Read More »

Twitter Facebook Linkedin Envelope CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines Freiburg, Germany & Monthey, Switzerland – PRESS RELEASE- Today, CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics …

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development Read More »

Twitter Facebook Linkedin Envelope The 2-year deal with Applitech Pharmaceutical Equipment Technology further strengthens BICO’s close collaboration and will see nearly 100 of CYTENA’s latest portfolio of cell isolators including the UP.SIGHT to be distributed to the massive Chinese life science market Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech …

CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies Read More »

Twitter Facebook Linkedin Envelope Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The platform combines CYTENA’s already proven single cell dispensing technology along with its best-in-class liquid handling expertise to enable affordable and high-quality laboratory automation. This combination of technologies advances BICO’s Bio Convergence agenda and democratizes access to …

CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies Read More »

Twitter Facebook Linkedin Envelope The #BIOCONVERGENCE revolution is here, and we’re proud to be leading the charge. Today, we embarked on our transition to BICO (formerly CELLINK), a new business structure concentrating on the intersection of biology and technology. Since our founding in 2016, we’ve built one of the world’s most expansive portfolio of life science products, …

We are now part of the BICO group Read More »

Twitter Facebook Linkedin Envelope It’s here! We’re launching our fastest single-cell dispenser with fluorescent sorting today!Our super-fast, highly efficient and gentle single-cell dispenser, the F.SIGHT™ 2.0, processes a 96-well plate in <2 minutes or a 384-well-plate in <7 minutes!Streamline your CLD, gene therapy or single-cell omics workflow with our newest patented F.SIGHT 2.0!

Twitter Facebook Linkedin Envelope CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell …

CYTENA Bioprocess Solutions launches S.NEST™ – The next-generation high-troughput microbioreactor for cell line development Read More »

Twitter Facebook Linkedin Envelope UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows.CYTENA GmbH, a CELLINK company and leader in single cell dispensing technologies, launches the UP.SIGHT, a transformative single-cell dispensing system that increases efficiency in cell line development workflows. This all-in-one solution is equipped with CYTENA’s …

CYTENA launches UP.SIGHT™, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality Read More »

Twitter Facebook Linkedin Envelope CYTENA GmbH and its affiliate CYTENA Bioprocess Solutions Ltd., part of CELLINK Life Sciences, announced today that they will collaborate with AstraZeneca to develop a new generation of plate-based microbioreactors that can improve the efficiency of cell line development workflows. CYTENA, which focuses on developing and commercializing innovative single-cell isolation and …

CYTENA and AstraZeneca collaborate to develop plate based microbioreactors for cell line development workflows Read More »